Original contribution
Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia

https://doi.org/10.1016/0891-5849(94)90191-0Get rights and content

Abstract

The pathophysiological importance of reactive oxygen species has been extensively documented in the pathogenesis of hepatic ischema-reperfusion injury. Kupffer cells and neutrophils were identified as the dominant sources of the postischemic oxidant stress. To test the hypothesis that a direct free radical-mediated injury mechanism (lipid peroxidation; LPO) may be involved in the pathogenesis, highly sensitive and specific parameters of LPO, i.e., hydroxy-eicosatetraenoic acids (HETES), and F2-isoprostanes, were determined by gas chromatographic-mass spectrometric analysis in liver tissue and plasma during 45 min of hepatic ischemia and up to 24 h of reperfusion. A significant 60–250% increase of F2-isoprostane levels in plasma was found at all times during reperfusion; the HETE content increased only significantly at 1 h of reperfusion and in severely necrotic liver tissue at 24 h with increases between 90–320%. On the other hand, in a model of LPO-induced liver injury (infusion of 0.8 μmol tert-butylhydroperoxide/min/g liver), the hepatic HETE content increased two to fourfold over baseline values at 45 min, i.e., before liver injury. A further increase to 12- to 30-fold of baseline was observed during moderate liver injury. Based on these quantitative comparisons of LPO and liver injury, it seems highly unlikely that LPO is the primary mechanism of parenchymal cell injury during reperfusion, although it cannot be excluded that LPO may be important as a damaging mechanism in a limited compartment of the liver, e.g., endothelial cells, close to the sources of reactive oxygen, e.g., Kupffer cells and neutrophils.

References (47)

  • H. Jaeschke et al.

    NADH-dependent reductive stress and ferritin-bound iron in allyl alcohol-induced lipid peroxidation in vivo: The protective effect of vitamin E

    Chem. Biol. Interact.

    (1992)
  • A. Wendel et al.

    Drug-induced lipid peroxidation in mice II: Protection against paracetamol-induced liver necrosis by intravenous liposomally entrapped glutathione

    Biochem. Pharmacol.

    (1982)
  • J.D. Morrow et al.

    Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramification for measurement of eicosanoids

    Anal. Biochem.

    (1990)
  • D.M. Guido et al.

    Quantitation of hydroperoxy-eicosatetraenoic acids and hydroxy-eicosatetraenoic acids as indicators of lipid peroxidation using gas chromatography-mass spectrometry

    Anal. Biochem.

    (1993)
  • H. Hughes et al.

    Role of leukotriene B4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat

    Prostaglandins, Leukotr. Essent. Fatty Acids

    (1992)
  • N. Masaki et al.

    tert-Butyl hydroperoxide kills cultured hepatocytes by peroxidizing membrane lipids

    Arch. Biochem. Biophys.

    (1989)
  • M.L. Lenz et al.

    Glutathione disulfide formation and lipid peroxidation during cardiac ischemia and reflow in the dog in vivo

    Biochem. Biophys. Res. Commun.

    (1989)
  • H. Sies et al.

    Oxidation in the NADP system and release of GSSG from hemoglobin-free perfused rat liver during peroxidatic oxidation of glutathione by hydroperoxides

    FEBS Lett.

    (1972)
  • H. Jaeschke et al.

    Pathophysiological consequences of enhanced intracellular superoxide formation in isolated perfused rat liver

    Chem. Biol. Interact.

    (1992)
  • H. Jaeschke et al.

    Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver

    J. Clin. Invest.

    (1988)
  • J. Metzger et al.

    Oxidant stress during reperfusion of ischemic liver: No evidence for a role of xanthine oxidase

    Hepatology

    (1988)
  • C.F. Babbs et al.

    Cytochemical studies of hydrogen peroxide generation in postischemic hepatocytes

    Am. J. Physiol.

    (1991)
  • H. Jaeschke et al.

    Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver

    Am. J. Physiol.

    (1991)
  • Cited by (165)

    • Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls

      2021, Acta Pharmaceutica Sinica B
      Citation Excerpt :

      However, under normal circumstances when animals are fed a regular diet, ethane exhalation and other LPO markers such as MDA only increased 2–3-fold112–114 or did not increase at all115. When compared to the orders of magnitude increase observed in known models of lipid peroxidation-induced cell death115,116, these comparatively small increases in LPO markers suggest that LPO does not occur at a high enough level to directly cause cell death in APAP hepatotoxicity. When measuring LPO markers in APAP-induced liver injury, which includes mainly MDA and HNE, quantitative aspects need to be kept in mind.

    • Oxidative stress and acute hepatic injury

      2018, Current Opinion in Toxicology
      Citation Excerpt :

      Interestingly, lipid peroxidation was considered the main mechanism by which oxidant stress causes cell death during hepatic ischemia-reperfusion and other liver disease processes [46]. However, many lipid peroxidation parameters are elevated only 2-to-3-times above baseline despite severe liver reperfusion injury [47]. In contrast, it was shown that it requires a very severe oxidant stress by t-butyl hydroperoxide to cause sufficient lipid peroxidation (50-times above baseline) that can kill hepatocytes [47].

    • Reactive Oxygen and Nitrogen Species and Liver Ischemia-Reperfusion Injury: An Overview

      2018, The Liver: Oxidative Stress and Dietary Antioxidants
    • Urinary F<inf>2</inf>-Isoprostane Concentration as a Poor Prognostic Factor After Subarachnoid Hemorrhage.

      2017, World Neurosurgery
      Citation Excerpt :

      For these reasons, urinary F2-IsoPs are among the most promising biomarkers of general oxidative stress. Elevated levels of urinary F2-IsoPs have been reported in numerous conditions, including alcoholic liver disease,33,34 hepatorenal syndrome,35 acute cholestasis,36,37 ischemia/reperfusion injury,38-41 diabetes,42,43 chronic obstructive pulmonary disease,44 allergic asthma,45 acute respiratory distress syndrome,46 Alzheimer disease,47-49 Huntington disease,50 retinopathy of prematurity,51,52 smoking,53,54 oxidative modification of low-density lipoprotein and atherogenesis,55-57 renal failure,58,59 and hyperhomocysteinemia.60 Therefore, we aimed to quantify urinary F2-IsoPs in patients with aSAH and to investigate their association with clinical aspects.

    View all citing articles on Scopus
    View full text